http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
-
Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer
-
Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ
-
Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting
-
Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020
-
Agilent Vaya Raman Raw Material ID Verification System Receives 2020 R&D 100 Award
-
Agilent Early Career Professor Award Presented to Carl DeSelm
-
Agilent Announces the Availability of Objective Decision Support for Pathologists Reviewing Breast Cancer Cases
-
Agilent Expands Line of Innovative Flow Cytometers with the NovoCyte Penteon
-
Agilent Announces Cash Dividend of 18 Cents Per Share
-
Agilent Announces Webcast for Investment Community
-
Agilent Announces SureSelect XT HS2 RNA Reagent Kit, a Library Prep and Target Enrichment Solution for RNA-Seq
-
Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model
-
Agilent Reports Third-Quarter Fiscal Year 2020 Financial Results
-
Agilent to Expand State-of-the-Art Manufacturing Capacity for Nucleic Acid-Based Therapeutics
-
Agilent to Webcast Third-Quarter Fiscal Year 2020 Financial Results Conference Call
-
Agilent Announces New Mass Spectrometry Products at ASMS 2020 Reboot
-
Agilent to Present at Jefferies Virtual Healthcare Conference
-
Agilent Reports Second-Quarter Fiscal Year 2020 Financial Results
-
Agilent Announces Cash Dividend of 18 Cents Per Share
-
Agilent Technologies (A) PD-L1 Assay Granted FDA Approval for Use as Companion Diagnostic
-
Agilent PD-L1 Assay Receives FDA Approval for Use as a Companion Diagnostic
-
Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral
-
Agilent Technologies (A) Receives FDA Approval for PD-L1 Companion Diagnostic on Dako Omnis
-
Agilent Receives FDA Approval for PD-L1 Companion Diagnostic on Dako Omnis
-
Agilent Signs Sponsorship Agreement with My Green Lab
-
Agilent Technologies (A) withdraws second-quarter and fiscal year 2020 guidance
-
Agilent Technologies Provides Update on COVID-19 Impact; Sets Second-Quarter Earnings Call for May 21
-
Agilent Introduces New Handheld Raw Material ID System for Pharmaceutical Manufacturers
-
Agilent Technologies to Change Location of Annual Meeting
-
Agilent Announces New Class 1 Triple Quadrupole LC/MS System
-
Ackman's hedge funds make money this year as hedges help
-
Agilent Technologies Announces Cash Dividend of 18 Cents Per Share
-
Agilent Technologies to Adjourn Annual Meeting Until April 17, 2020
-
Agilent Introduces CrossLab Connect Services for Lab-wide Asset Monitoring
-
Agilent Receives Two Scientists’ Choice Awards
-
Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research
-
Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions
-
Agilent Technologies Announces Webcasts for Investment Community
-
Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results
-
Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation
-
Twist Bioscience Corporation (TWST) Confirms Settlement with Agilent (A)
-
Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics
-
Agilent Technologies to Webcast First Quarter Fiscal Year 2020 Financial Results Conference Call
-
Agilent Introduces New Cutting-Edge SureSelect DNA Kit
-
Agilent Announces CrossLab Group Leadership Transition
-
Agilent Wins Multiple Innovation Awards
-
Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema
-
Agilent Expands Cross-Vendor CDS Instrument Control
-
Agilent Compliance Services Voted No. 1 in Global Survey

